394 related articles for article (PubMed ID: 31307919)
1. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.
Shoeibi A; Litvan I; Tolosa E; Ser TD; Lee E;
Parkinsonism Relat Disord; 2019 Sep; 66():87-93. PubMed ID: 31307919
[TBL] [Abstract][Full Text] [Related]
2. A Fully Automated, Atlas-Based Approach for Superior Cerebellar Peduncle Evaluation in Progressive Supranuclear Palsy Phenotypes.
Nicoletti G; Caligiuri ME; Cherubini A; Morelli M; Novellino F; Arabia G; Salsone M; Quattrone A
AJNR Am J Neuroradiol; 2017 Mar; 38(3):523-530. PubMed ID: 28034996
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.
Quattrone A; Morelli M; Quattrone A; Vescio B; Nigro S; Arabia G; Nisticò R; Novellino F; Salsone M; Arcuri P; Luca A; Mazzuca A; Alessio C; Rocca F; Caracciolo M
Parkinsonism Relat Disord; 2020 Mar; 72():1-6. PubMed ID: 32036297
[TBL] [Abstract][Full Text] [Related]
4. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
[TBL] [Abstract][Full Text] [Related]
5. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
[TBL] [Abstract][Full Text] [Related]
6. Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy.
Pilotto A; Gazzina S; Benussi A; Manes M; Dell'Era V; Cristillo V; Cosseddu M; Turrone R; Alberici A; Padovani A; Borroni B
Neurodegener Dis; 2017; 17(6):286-291. PubMed ID: 28881351
[TBL] [Abstract][Full Text] [Related]
7. Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.
Lopez G; Bayulkem K; Hallett M
Acta Neurol Scand; 2016 Oct; 134(4):242-9. PubMed ID: 27070344
[TBL] [Abstract][Full Text] [Related]
8. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
Shoeibi A; Litvan I; Juncos JL; Bordelon Y; Riley D; Standaert D; Reich SG; Shprecher D; Hall D; Marras C; Kluger B; Olfati N; Jankovic J
Parkinsonism Relat Disord; 2019 Dec; 69():34-39. PubMed ID: 31665686
[TBL] [Abstract][Full Text] [Related]
9. Progressive Supranuclear Palsy: an Update.
Armstrong MJ
Curr Neurol Neurosci Rep; 2018 Feb; 18(3):12. PubMed ID: 29455271
[TBL] [Abstract][Full Text] [Related]
10. Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism.
Steele JC; Caparros-Lefebvre D; Lees AJ; Sacks OW
Parkinsonism Relat Disord; 2002 Oct; 9(1):39-54. PubMed ID: 12217621
[TBL] [Abstract][Full Text] [Related]
11. Protracted course progressive supranuclear palsy.
Couto B; Martinez-Valbuena I; Lee S; Alfradique-Dunham I; Perrin RJ; Perlmutter JS; Cruchaga C; Kim A; Visanji N; Sato C; Rogaeva E; Lang AE; Kovacs GG
Eur J Neurol; 2022 Aug; 29(8):2220-2231. PubMed ID: 35384155
[TBL] [Abstract][Full Text] [Related]
12. Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants.
Street D; Malpetti M; Rittman T; Ghosh BCP; Murley AG; Coyle-Gilchrist I; Passamonti L; Rowe JB
Brain Commun; 2021; 3(3):fcab206. PubMed ID: 34541533
[TBL] [Abstract][Full Text] [Related]
13. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
Litvan I; Agid Y; Calne D; Campbell G; Dubois B; Duvoisin RC; Goetz CG; Golbe LI; Grafman J; Growdon JH; Hallett M; Jankovic J; Quinn NP; Tolosa E; Zee DS
Neurology; 1996 Jul; 47(1):1-9. PubMed ID: 8710059
[TBL] [Abstract][Full Text] [Related]
14. Familial aggregation of parkinsonism in progressive supranuclear palsy.
Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
[TBL] [Abstract][Full Text] [Related]
15. Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.
Street D; Jabbari E; Costantini A; Jones PS; Holland N; Rittman T; Jensen MT; Chelban V; Goh YY; Guo T; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Houlden H; Morris H; Rowe JB
Brain; 2023 Aug; 146(8):3232-3242. PubMed ID: 36975168
[TBL] [Abstract][Full Text] [Related]
16. Vestibular symptoms as the presenting feature of progressive supranuclear palsy.
Haggstrom L; Brew B; Sutton I; Tisch S
J Clin Neurosci; 2018 Apr; 50():74-76. PubMed ID: 29398194
[TBL] [Abstract][Full Text] [Related]
17. Abnormal structural connectivity in progressive supranuclear palsy-Richardson syndrome.
Prasad S; Rajan A; Pasha SA; Mangalore S; Saini J; Ingalhalikar M; Pal PK
Acta Neurol Scand; 2021 Apr; 143(4):430-440. PubMed ID: 33175396
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
Pagonabarraga J; Horta-Barba A; Busteed L; Bejr-Kasem H; Illán-Gala I; Aracil-Bolaños I; Marín-Lahoz J; Pascual-Sedano B; Pérez J; Campolongo A; Izquierdo C; Martinez-Horta S; Sampedro F; Kulisevsky J
Parkinsonism Relat Disord; 2021 Apr; 85():63-68. PubMed ID: 33744691
[TBL] [Abstract][Full Text] [Related]
19. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
[TBL] [Abstract][Full Text] [Related]
20. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
